Search Filters

Search Results

Found 3 results

510(k) Data Aggregation

    K Number
    K111227
    Manufacturer
    Date Cleared
    2011-05-13

    (11 days)

    Product Code
    Regulation Number
    892.1550
    Why did this record match?
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The device is intended for use by a qualified physician for ultrasound evaluation of Small Parts, Abdominal, Cardiac, Peripheral Vascular, Fetal, Intra-operative, Intra-operative (Cardiac), Trans-vaginal, Trans-rectal, Gynecological, Pediatric, Laparoscopic, and Neonatal Cephalic applications. The device is not indicated for Ophthalmic applications.

    Device Description

    The SSD-3500 Diagnostic Ultrasound System is a full feature imaging and analysis system. It consist of a mobile console that provides acquisition, processing and display capability. The user interface includes a computer type keyboard, specialized controls and a display.

    AI/ML Overview

    Here's an analysis of the provided information regarding the Aloka SSD-3500 Ver. 7.8 Diagnostic Ultrasound System:

    1. Table of Acceptance Criteria and Reported Device Performance

    The provided document is a 510(k) premarket notification for a diagnostic ultrasound system. In a 510(k) submission for a device like this, the "acceptance criteria" are generally that the new device (Aloka SSD-3500 Ver. 7.8) demonstrates substantial equivalence to a previously cleared predicate device (Aloka SSD-3500 Ver. 7.0). This means the new device must have the same intended use, similar technological characteristics, and demonstrate similar safety and effectiveness.

    Since this is a substantial equivalence claim for an ultrasound system, the acceptance criteria don't typically involve specific performance metrics like sensitivity or specificity in a diagnostic task, but rather confirmation that the device functions as intended and meets relevant safety standards.

    Acceptance Criteria (Implicit for Substantial Equivalence)Reported Device Performance (as stated in the submission)
    Safety:
    - Conformance to applicable medical device safety standards (acoustic output, biocompatibility, cleaning & disinfection, electromagnetic compatibility, electrical, mechanical safety)."The device and its transducers have been evaluated for acoustic output, biocompatibility, cleaning & disinfection effectiveness, electromagnetic compatibility, as well as electrical and mechanical safety, and have been found to conform with applicable medical device safety standards." Additionally, "The device conforms to applicable medical device safety standards and compliance is verified through independent evaluation with ongoing factory surveillance."
    Effectiveness:
    - Same intended uses as the predicate device."It has the same... intended uses... as the predicate device." The system's intended uses are: Small Parts, Abdominal, Cardiac, Peripheral Vascular, Fetal, Intra-operative, Intra-operative (Cardiac), Trans-vaginal, Trans-rectal, Gynecological, Pediatric, Laparoscopic, and Neonatal Cephalic applications. (Ophthalmic applications are excluded).
    - Similar technological characteristics and basic operating modes as the predicate device."The Aloka SSD-3500 Ver. 7.8 is technically comparable and substantially equivalent to the current Aloka SSD-3500 Ver. 7.0 -(K060059). It has the same technological characteristics, key safety and effectiveness features, and has the same intended uses and basic operating modes as the predicate device." The device description mentions it is a "full feature imaging and analysis system" providing acquisition, processing, and display capability through a "computer type keyboard, specialized controls and a display." The specific operating modes (A, B, M, PWD, CWD, Color Doppler, Amplitude Doppler, Color Velocity Imaging, Combined) are listed for each transducer and clinical application.
    - No new questions of safety or effectiveness are raised compared to the predicate device."Intended uses and other key features are consistent with traditional clinical practices, FDA guidelines and established methods of patient examination. The design, development and quality process of the manufacturer confirms with 21 CFR 820, ISO 9001:2000 and ISO 13485 quality systems. The device conforms to applicable medical device safety standards and compliance is verified through independent evaluation with ongoing factory surveillance. Diagnostic ultrasound has accumulated a long history of safe and effectiveness performance. Therefore, it is the opinion of Aloka Co., Ltd. that the Aloka SSD-3500 Ver. 7.8 Ultrasound System and its transducers are substantially equivalent with respect to safety and effectiveness to its predicate and other currently cleared Aloka systems."

    2. Sample Size Used for the Test Set and the Data Provenance

    The document explicitly states: "2. Clinical Tests: None Required."
    Therefore, there is no test set, sample size, or data provenance related to clinical performance testing for this submission. The device's substantial equivalence is based on technical specifications and comparison to a predicate device, not on new clinical performance data from a specific test set.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts

    Since no clinical tests were required, there was no test set and therefore no ground truth established by experts for performance evaluation in this submission.

    4. Adjudication Method for the Test Set

    As there was no clinical test set, no adjudication method was used for establishing ground truth.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

    No MRMC comparative effectiveness study was conducted or required for this 510(k) submission. This device is a diagnostic ultrasound system, not an AI-powered diagnostic application that would typically undergo such a study to evaluate human reader improvement with AI assistance.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    No standalone algorithm performance study was conducted. This device is a conventional diagnostic ultrasound system, not an artificial intelligence algorithm that would typically have a standalone performance evaluation.

    7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)

    As mentioned above, no specific clinical ground truth was established for performance evaluation in this 510(k) submission because clinical testing was not required. The "ground truth" for the submission is the regulatory acceptance of its predicate device (Aloka SSD-3500 Ver. 7.0) and the demonstrated technical equivalence and adherence to safety standards.

    8. The Sample Size for the Training Set

    Since no AI/machine learning algorithm is part of this submission, there is no training set mentioned or used.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable, as there is no training set for an AI/machine learning algorithm in this submission.


    Summary of the Study that Proves the Device Meets Acceptance Criteria:

    The study that proves the Aloka SSD-3500 Ver. 7.8 Diagnostic Ultrasound System meets its acceptance criteria is a technical and regulatory comparison study against a legally marketed predicate device, the Aloka SSD-3500 Ver. 7.0 (K060059).

    The manufacturer (Aloka Co., Ltd.) provided documentation and analysis demonstrating that the new version is "technically comparable and substantially equivalent" to the predicate. This involved:

    • Documentation of Shared Characteristics: Confirming that the Aloka SSD-3500 Ver. 7.8 has the "same technological characteristics, key safety and effectiveness features, and has the same intended uses and basic operating modes" as the predicate device.
    • Non-Clinical Testing: The device and its transducers underwent various non-clinical evaluations to confirm compliance with applicable medical device safety standards. These tests covered:
      • Acoustic output
      • Biocompatibility
      • Cleaning & disinfection effectiveness
      • Electromagnetic compatibility
      • Electrical safety
      • Mechanical safety
    • Quality System Conformance: The manufacturer confirmed that their design, development, and quality processes align with 21 CFR 820, ISO 9001:2000, and ISO 13485 quality systems.

    The FDA's review of this submission found that "the device is substantially equivalent... to legally marketed predicate devices," thus confirming it meets the regulatory acceptance criteria for market clearance. Clinical testing was not required because the device was demonstrating equivalence to an already approved device and no new questions of safety or effectiveness were raised.

    Ask a Question

    Ask a specific question about this device

    K Number
    K110207
    Manufacturer
    Date Cleared
    2011-02-17

    (23 days)

    Product Code
    Regulation Number
    892.1550
    Why did this record match?
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The device is intended for use by a qualified physician for ultrasound evaluation of Small Parts, Abdominal, Cardiac, Peripheral Vascular, Fetal, Intra-operative, Trans-vaginal , Trans-rectal, Gynecological, Musculo-sketal and Neonatal Cephalic applications. The device is not indicated for Ophthalmic applications.

    Device Description

    The Prosound F75 Diagnostic Ultrasound System is a full feature imaging and analysis system. It consist of a mobile console that provides acquisition, processing and display capability. The user interface includes a computer type keyboard, specialized controls and a display.

    AI/ML Overview

    The provided document is a 510(k) summary for the Aloka Prosound F75 Diagnostic Ultrasound System. This document focuses on demonstrating substantial equivalence to a predicate device, rather than proving performance against specific acceptance criteria through a clinical study for a novel device. Therefore, many of the requested categories for acceptance criteria and clinical study details are not applicable in this context.

    Here's a breakdown based on the information provided:

    1. Table of Acceptance Criteria and Reported Device Performance

    For a traditional medical device like an ultrasound system undergoing 510(k) clearance, the "acceptance criteria" are generally established through engineering and performance testing against recognized standards to demonstrate that the device performs as intended and is safe and effective. The "reported device performance" is then the outcome of these non-clinical tests. The key acceptance criterion for a 510(k) is substantial equivalence to a predicate device.

    Acceptance Criterion (Implicit)Reported Device Performance
    Substantial Equivalence to Predicate DeviceThe Aloka Prosound F75 is deemed technically comparable and substantially equivalent to the Aloka Alpha 10 (K043196). It possesses the same technological characteristics, key safety and effectiveness features, intended uses, and basic operating modes.
    Compliance with Applicable Medical Device Safety StandardsThe device and its transducers (listed: UST-567, UST-675P, ASU-1010, UST-2265-2, UST-2266-5, UST-5293-5, UST-5411, UST-5415, UST-9118, UST-9130, UST-9133, UST-9146I, UST-9146T, UST-9147, UST-52105, UST-52119S, UST-52121S, UST-52124) have been evaluated for:
    • Acoustic output
    • Biocompatibility
    • Cleaning & disinfection effectiveness
    • Electromagnetic compatibility
    • Electrical and mechanical safety.
      They were found to conform with applicable medical device safety standards. |
      | Quality System Compliance | The design, development, and quality process conforms with 21 CFR 820, ISO 9001:2000, and ISO 13485 quality systems. |
      | Intended Use Alignment with Traditional Clinical Practices | Intended uses and other key features are consistent with traditional clinical practices and FDA guidelines. |

    Study Details:

    For this 510(k) submission, the primary "study" is the demonstration of substantial equivalence through non-clinical testing and comparison to a legally marketed predicate device.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Sample Size for Test Set: Not applicable for this type of submission. This 510(k) does not involve a clinical test set in the way a novel AI device might. The review is based on internal technical evaluations, compliance with standards, and comparison to a predicate device.
    • Data Provenance: Not applicable. The "data" are primarily technical specifications, test reports for acoustic output, biocompatibility, etc., and a comparison matrix to the predicate device. These are internal company documents and safety standard compliance reports.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    • Number of Experts & Qualifications: Not applicable. Ground truth, in the context of clinical studies with expert consensus, is not part of this 510(k) pathway for an ultrasound system. The "ground truth" here is adherence to engineering specifications and safety standards, and functional equivalence to the predicate device.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • Adjudication Method: Not applicable. This concept pertains to resolving discrepancies in expert labeling or diagnoses in clinical studies, which were not conducted for this submission.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • MRMC Comparative Effectiveness Study: No. This device is a diagnostic ultrasound system, not an AI-powered image analysis tool designed to assist human readers, or a novel therapy. Therefore, an MRMC study is not relevant to its clearance.

    6. If a standalone (i.e. algorithm only, without human-in-the loop performance) was done

    • Standalone Performance Study: No. This device is an imaging system operated by a human physician, not an algorithm, and the concept of "standalone performance" for an algorithm is not applicable.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    • Type of Ground Truth: The "ground truth" in this context is the established safety and effectiveness of the predicate device (Aloka Alpha 10), and the objective measurements demonstrating that the new device meets recognized safety and performance standards (e.g., acoustic output limits, electrical safety, biocompatibility, cleaning efficacy).

    8. The sample size for the training set

    • Sample Size for Training Set: Not applicable. This is not an AI/machine learning device that requires a training set.

    9. How the ground truth for the training set was established

    • Ground Truth for Training Set Establishment: Not applicable. As this is not an AI/machine learning device, there is no training set or associated ground truth for it.

    In summary: The Aloka Prosound F75 Diagnostic Ultrasound System obtained 510(k) clearance by demonstrating substantial equivalence to a predicate device (Aloka Alpha 10) through technical comparisons and compliance with recognized safety and performance standards. It did not involve clinical trials, expert consensus studies, or AI algorithm performance evaluations as typically seen for novel software or AI/ML devices.

    Ask a Question

    Ask a specific question about this device

    K Number
    K032875
    Manufacturer
    Date Cleared
    2003-09-30

    (15 days)

    Product Code
    Regulation Number
    892.1560
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Reference Devices :

    SSD-1700 (K963616), SSD-5500 Ver.3.1 (K992663), SSD-5500 Ver.4.2 (K002784/ K011457), SSD-5500 Ver. 4.2.2

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Fetal, Abdominal, Intraoperative (specify), Intraoperative Neurological, Pediatric, Small Organ (specify), Neonatal Cephalic, Adult Cephalic, Cardiac, Transesophageal, Transrectal, Transvaginal, Peripheral Vascular, Laparoscopic, Musculo-skeletal Conventional, Musculo-skeletal Superficial. Mixed mode operation includes B/M, B/PWD, B/Bflow/PWD. Intraoperative applications: include liver, pancreas and gall bladder. Small parts applications include breast, testes and thyroid.

    Device Description

    The Aloka SSD-5500 V6.0 functions in the same manner as other diagnostic ultrasound devices. High frequency sound waves are transmitted into the body by a piezo-electric transducer. In the body, differences in the acoustic impedance of different tissues reflect a certain amount of the ultrasound energy back to the transducer, where it is transmitted via the probe cable to the system console and processed into an image. The Aloka SSD-5500 V6.0 transducer can also use the Doppler shift of sound reflected from moving tissues (blood) to detect and display flow.

    AI/ML Overview

    The provided text is a 510(k) summary for the Aloka Model SSD-5500 V6.0 Diagnostic Ultrasound System. This type of submission focuses on demonstrating substantial equivalence to a predicate device, rather than providing detailed clinical study performance metrics or acceptance criteria for a novel AI algorithm. Therefore, much of the requested information regarding acceptance criteria and performance against those criteria, as well as specific details about test and training sets, expert qualifications, and comparative effectiveness studies, is not present in this document.

    However, based on the provided text, here's what can be extracted and inferred:

    1. Table of Acceptance Criteria and Reported Device Performance:

    The document doesn't present specific quantitative acceptance criteria or detailed performance metrics. Instead, it relies on demonstrating substantial equivalence to predicate devices. The "reported device performance" is implicitly that it performs equivalently to the listed predicate devices across various clinical applications and operation modes.

    Acceptance Criteria CategoryReported Device PerformanceComments
    Technological Characteristics- Uses essentially the same technologies for imaging, Doppler functions, and signal processing as predicate devices (SSD-1700, SSD-5500 V3.1, V4.2, V4.2.2).This indicates that its fundamental operation and expected performance are on par with established devices.
    Method of Use- Has the same method of use as predicate devices.Ensures similar user interaction and clinical workflow.
    Acoustic Power Output Levels- Below the maximum levels allowed by the FDA.Complies with safety regulations.
    Quality Assurance- Subjected to the same Quality Assurance systems in development and production as predicate devices.Implies adherence to established manufacturing and testing standards for reliability and safety.
    Patient Contact Materials- Evaluated for safety via the same standards and methods as predicate devices; found safe for intended uses.Focuses on biocompatibility and safety for patient contact.
    Electrical and Physical Safety Standards- Complies with electrical and physical safety standards (NEMA-UD2: 1992, AIUM 1994, IEC-60601-1, UL 2601-1, ISO10993-1). All testing completed and results meet requirements.Demonstrates adherence to recognized international safety and performance standards.
    Indications for Use (with Transducers)The device, with its various transducers, supports a wide range of clinical applications including: Fetal, Abdominal, Intraoperative (liver, pancreas, gall bladder), Pediatric, Small Organ (breast, testes, thyroid), Neonatal Cephalic, Adult Cephalic, Cardiac, Transesophageal, Transrectal, Transvaginal, Peripheral Vascular, Laparoscopic, Musculo-skeletal (Conventional & Superficial). For most applications, the device's capability (B, M, PWD, Color Doppler, Amplitude Doppler) is marked as "P" (previously cleared by FDA) or "E" (added under Appendix E), indicating equivalence to or extension of existing cleared indications.This is the primary "performance" stated, demonstrating its clinical utility across various body regions and diagnostic modes, consistent with predicate devices.

    2. Sample Size Used for the Test Set and Data Provenance:

    • The document does not explicitly state a sample size for a test set or the provenance (country of origin, retrospective/prospective) of any specific data used to evaluate the substantial equivalence from a performance perspective.
    • The evaluation appears to be based on a comparison to characteristics and performance of existing legally marketed predicate devices, rather than a new clinical study with a distinct test set for performance metrics. The tables listing "P" (previously cleared by FDA) and "E" (added under Appendix E) suggest that the current device is being compared to the established performance of the predicate device for those indications.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of those Experts:

    • This information is not provided in the document.
    • Given that this is a 510(k) submission asserting substantial equivalence to predicate devices, it's unlikely that new "ground truth" establishment by a panel of experts for a novel device performance study was required or conducted in the manner of a de novo submission. The "ground truth" for the predicate devices' performance would have been established during their initial clearances.

    4. Adjudication Method:

    • This information is not provided in the document.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • This information is not applicable and therefore not provided. The Aloka SSD-5500 V6.0 is a diagnostic ultrasound system, not an AI-powered image analysis or diagnostic aid designed to be used in conjunction with human readers to improve their performance. It's a standalone imaging device.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • The device being evaluated is a standalone diagnostic ultrasound system. Its performance is inherently "standalone" in the sense that it generates images and Doppler information directly. However, it is not an "algorithm only" device; it's a complete hardware and software system for image acquisition and display. The clinical performance is tied to the images and data it produces, which are then interpreted by a human operator/physician.

    7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.):

    • For the purpose of this 510(k) submission, the "ground truth" for the new device's performance is established by demonstrating its substantial equivalence to the performance and characteristics of its predicate devices. The predicate devices themselves would have had their performance (and hence their implicitly "ground-truth-validated" capabilities) established through various means at the time of their clearance, which could have included expert consensus, physical phantom testing, and clinical evaluations. The document does not specify how the predicate devices' performance was originally validated, only that the new device meets those established standards.

    8. The Sample Size for the Training Set:

    • This information is not applicable and therefore not provided. This device is a traditional diagnostic ultrasound system, not an AI/ML-driven device that requires a "training set" of data in the sense typically associated with machine learning algorithms.

    9. How the Ground Truth for the Training Set was Established:

    • This information is not applicable and therefore not provided, as the device doesn't rely on a "training set" in the AI/ML context.

    In summary:

    This 510(k) submission for the Aloka Model SSD-5500 V6.0 Diagnostic Ultrasound System primarily demonstrates its substantial equivalence to previously cleared predicate devices by comparing their technological characteristics, methods of use, safety, and indications. It does not contain details about specific clinical studies with distinct acceptance criteria, test/training sets, or expert ground truth establishment as would be expected for a novel AI/ML device. The "proof" the device meets acceptance criteria is fundamentally its demonstrated sameness in key aspects to already cleared devices and adherence to relevant safety standards.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1